SynBac
Traditional process scale up using baculovirus is notoriously problematic, with yields dropping progressively during scale up. SynBac™ are minimized baculoviral genomes created using modern synthetic biology techniques. The SynBac™ project aims to transform fermenter-scale baculoviral production of drug targets, and manufacturing scale production of biopharmaceuticals by creating minimal baculoviral genomes displaying exceptional DNA stability. In addition to improved DNA stability, our minimized genomes form the starting point for applications that require large DNA cargo delivery to mammalian cells, primary cells, or organs.
17th Oct 2020
Recent Posts
-
Ask a quote for the following applications
Instruments 2 Mag reagents 3M kits 77 Elektronika tests A instrumen …14th Apr 2022 -
Single Domain Antibodies: Therapeutic Tools for the Future?
In this blog, ProSci will take you through the advantages of single-domain antibodies (sdAbs)—also k …28th Mar 2022 -
GelRed and GelGreen– non-toxic nucleic acid stains as an alternative to EtBr
Ethidium Bromide (EtBr) has become the most used dye for nucleic acid staining due to its low cost …31st Aug 2021